304 related articles for article (PubMed ID: 31154939)
1. Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.
Ranchoux B; Nadeau V; Bourgeois A; Provencher S; Tremblay É; Omura J; Coté N; Abu-Alhayja'a R; Dumais V; Nachbar RT; Tastet L; Dahou A; Breuils-Bonnet S; Marette A; Pibarot P; Dupuis J; Paulin R; Boucherat O; Archer SL; Bonnet S; Potus F
Circ Res; 2019 Aug; 125(4):449-466. PubMed ID: 31154939
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
[TBL] [Abstract][Full Text] [Related]
3. Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/MAPK pathway and the expression of IL-6 and TNF-α.
Huang W; Liu H; Pan Y; Yang H; Lin J; Zhang H
J Cardiothorac Surg; 2021 May; 16(1):127. PubMed ID: 33971931
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
Satoh T; Wang L; Espinosa-Diez C; Wang B; Hahn SA; Noda K; Rochon ER; Dent MR; Levine AR; Baust JJ; Wyman S; Wu YL; Triantafyllou GA; Tang Y; Reynolds M; Shiva S; Hilaire CS; Gomez D; Goncharov DA; Goncharova EA; Chan SY; Straub AC; Lai YC; McTiernan CF; Gladwin MT
Circulation; 2021 Aug; 144(8):615-637. PubMed ID: 34157861
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
[TBL] [Abstract][Full Text] [Related]
6. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone attenuates pulmonary artery and right ventricular remodeling in a rat model of pulmonary hypertension due to left heart failure.
Zhang YT; Xue JJ; Wang Q; Cheng SY; Chen ZC; Li HY; Shan JJ; Cheng KL; Zeng WJ
Life Sci; 2019 Feb; 219():82-89. PubMed ID: 30605649
[TBL] [Abstract][Full Text] [Related]
8. Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice.
Tian Q; Fan X; Ma J; Li D; Han Y; Yin X; Wang H; Huang T; Wang Z; Shentu Y; Xue F; Du C; Wang Y; Mao S; Fan J; Gong Y
FASEB J; 2021 Aug; 35(8):e21822. PubMed ID: 34314061
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.
Hunt JM; Bethea B; Liu X; Gandjeva A; Mammen PP; Stacher E; Gandjeva MR; Parish E; Perez M; Smith L; Graham BB; Kuebler WM; Tuder RM
Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L725-36. PubMed ID: 24039255
[TBL] [Abstract][Full Text] [Related]
10. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.
Savale L; Tu L; Rideau D; Izziki M; Maitre B; Adnot S; Eddahibi S
Respir Res; 2009 Jan; 10(1):6. PubMed ID: 19173740
[TBL] [Abstract][Full Text] [Related]
11. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; Rucker-Martin C; Brás-Silva C; Quarck R; Domergue V; Vachiéry JL; Humbert M; Perros F; Montani D; Antigny F
Cardiovasc Res; 2021 Nov; 117(12):2474-2488. PubMed ID: 33483721
[TBL] [Abstract][Full Text] [Related]
12. Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension.
Udjus C; Cero FT; Halvorsen B; Behmen D; Carlson CR; Bendiksen BA; Espe EKS; Sjaastad I; Løberg EM; Yndestad A; Aukrust P; Christensen G; Skjønsberg OH; Larsen KO
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L999-L1012. PubMed ID: 30908936
[TBL] [Abstract][Full Text] [Related]
13. Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction.
Pandolfi R; Barreira B; Moreno E; Lara-Acedo V; Morales-Cano D; Martínez-Ramas A; de Olaiz Navarro B; Herrero R; Lorente JÁ; Cogolludo Á; Pérez-Vizcaíno F; Moreno L
Thorax; 2017 May; 72(5):460-471. PubMed ID: 27701117
[TBL] [Abstract][Full Text] [Related]
14. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
Meloche J; Lampron MC; Nadeau V; Maltais M; Potus F; Lambert C; Tremblay E; Vitry G; Breuils-Bonnet S; Boucherat O; Charbonneau E; Provencher S; Paulin R; Bonnet S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1513-1523. PubMed ID: 28473439
[TBL] [Abstract][Full Text] [Related]
15. Animal models of pulmonary hypertension due to left heart disease.
Liu SF; Yan Y
Animal Model Exp Med; 2022 Sep; 5(3):197-206. PubMed ID: 35234367
[TBL] [Abstract][Full Text] [Related]
16. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
[TBL] [Abstract][Full Text] [Related]
17. The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease.
Wang Q; Guo YZ; Zhang YT; Xue JJ; Chen ZC; Cheng SY; Ou MD; Cheng KL; Zeng WJ
PLoS One; 2016; 11(7):e0157171. PubMed ID: 27388289
[TBL] [Abstract][Full Text] [Related]
18. Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-β1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats.
Zhang H; Huang W; Liu H; Zheng Y; Liao L
PLoS One; 2020; 15(9):e0235824. PubMed ID: 32881898
[TBL] [Abstract][Full Text] [Related]
19. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
20. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
